Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Point-of-care washed red blood cells are a specialized blood product preparation where allogeneic leukocyte-reduced red blood cells are washed with saline using an automated system immediately before transfusion. This process is intended to reduce the risk of transfusion-related complications, specifically transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO), by removing potentially harmful substances that accumulate during storage, such as free hemoglobin, extracellular potassium, pro-inflammatory cytokines, and lipids. This intervention is primarily being evaluated in high-risk populations, such as patients undergoing cardiac surgery, where large-volume transfusions are common and the risk of pulmonary complications is elevated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Point-of-care washed red blood cells.